Evidence map›Paper›PMID 22133886›Full record

ReviewThe Journal of clinical investigation2011

Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Rebecca M Brotman

Registry-linked trialAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07408271 (The Impact of Rabeprazole-based Triple Therapy Plus Bismuth for First-line Helicobacter Pylori Eradication on the Vaginal Microecology Change), which is not on this map. Cited by 155 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07408271 completednot on this mapstarted 2023, after this paper: background citation

The Impact of Rabeprazole-based Triple Therapy Plus Bismuth for First-line Helicobacter Pylori Eradication on the Vaginal Microecology Change: a Prospective, Randomized Controlled Trial

TypeobservationalSponsorSecond Affiliated Hospital, Zhejiang University, School of MedicineRan2023 to 2024Enrolled83ConditionsHelicobacter Pylori Infection, Helicobacter Pylori Eradication AntibioticArmsrabeprazole-based triple therapy plus bismuth H. pylori eradication therapy
3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Orally administratedFrontiers in immunology · 2023
    Trial
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Review
  12. The Gut-Vagina Axis.Microorganisms · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Progress in interventions for vaginal microecology.Frontiers in cellular and infection microbiology · 2026
    Review

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rebecca M BrotmanDepartment of Epidemiology and Public Health and Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. rbrotman@som.umaryland.edu

Funding

Molecular Epidemiology of the Vaginal MicrobiomeK01AI080974 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROTMAN, REBECCA M. · 2010 to 2014
$644k
NIAID NIH HHS K01 AI080974NIAID NIH HHS K01-AI080974
6 · The paper itself

Abstract

Vaginal bacterial communities are thought to help prevent sexually transmitted infections. Bacterial vaginosis (BV) is a common clinical syndrome in which the protective lactic acid-producing bacteria (mainly species of the Lactobacillus genus) are supplanted by a diverse array of anaerobic bacteria. Epidemiologically, BV has been shown to be an independent risk factor for adverse outcomes including preterm birth, development of pelvic inflammatory disease, and acquisition of sexually transmitted infections. Longitudinal studies of the vaginal microbiome using molecular techniques such as 16S ribosomal DNA analysis may lead to interventions that shift the vaginal microbiota toward more protective states.

Indexed as

MetagenomeBacteria, AnaerobicDisease SusceptibilityFemaleGram-Negative BacteriaGram-Positive BacteriaHumansHydrogen-Ion ConcentrationInfant, Low Birth WeightInfant, NewbornLactobacillusMicrobial InteractionsObstetric Labor, PrematurePregnancyPregnancy Complications, InfectiousRibotyping

Identifiers

PMID22133886
PMCPMC3225992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.